Abou Family Residence (XTAE:ABOU) Research & Development: ₪ Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ABOU Abou Family Residence Ltd XTAE:ABOU
21 GF Score
Price ₪6.05
! 1 Warning Sign
View Full Analysis

What is Abou Family Residence Research & Development?

Abou Family Residence XTAE:ABOU 21 Research & Development is ₪ Mil as of . 20. GuruFocus rates XTAE:ABOU with a GF Score™ of 21/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Abou Family Residence's Research & Development for the six months ended in . 20 was ₪0.00 Mil. Abou Family Residence does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Abou Family Residence  (XTAE:ABOU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Abou Family Residence Research & Development Related Terms

Abou Family Residence Research & Development Historical Data

* Premium members only.

The historical data trend for Abou Family Residence's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abou Family Residence Research & Development Chart

Abou Family Residence Annual Data
Trend
Research & Development

Abou Family Residence Semi-Annual Data
Research & Development
XTAE:ABOU
21GF Score
Abou Family Residence Ltd XTAE:ABOU
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abou Family Residence Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₪ Mil mean?
Abou Family Residence (XTAE:ABOU) has a Research & Development of ₪ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Abou Family Residence and its competitors.
Is Abou Family Residence's Research & Development too high?
Abou Family Residence's current Research & Development is ₪ Mil. Overall, Abou Family Residence has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Abou Family Residence's Research & Development compare to ABT and SYK?
Abou Family Residence's Research & Development of ₪ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Abou Family Residence and its competitors. Abou Family Residence's current Research & Development is ₪ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abou Family Residence stock overvalued right now?
Abou Family Residence (XTAE:ABOU) has a current Research & Development of ₪ Mil. The current Research & Development is ₪ Mil. Abou Family Residence's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Abou Family Residence (XTAE:ABOU), the current Research & Development is ₪ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Abou Family Residence Business Description

Address 7 Haarad Street, Tel-Aviv, ISR, 6971060
Abou Family Residence Ltd formerly Envizion Medical Ltd is a medical device company. It is focused on improving patient outcomes across the continuum of care, encompassing the development of advanced, personalized navigation technology for feeding tubes, responding to the challenges of the ever changing healthcare environment, while continuously focusing on the customer.
21GF Score

Get the complete analysis for XTAE:ABOU

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪6.05
Price